|
RG9MTD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.66133814775094E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.6304735339645E-12 |
| Normal-vs-Stage2 |
1.39259714870832E-11 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
4.150400E-01 |
| Stage1-vs-Stage3 |
2.639000E-03 |
| Stage1-vs-Stage4 |
7.304400E-02 |
| Stage2-vs-Stage3 |
1.120300E-02 |
| Stage2-vs-Stage4 |
7.241700E-02 |
| Stage3-vs-Stage4 |
3.147400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62558855265615E-12 |
| Normal-vs-AfricanAmerican |
<1E-12 |
| Normal-vs-Asian |
5.939900E-03 |
| Caucasian-vs-AfricanAmerican |
4.016900E-03 |
| Caucasian-vs-Asian |
3.979800E-01 |
| AfricanAmerican-vs-Asian |
3.155900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62481139653892E-12 |
| Normal-vs-Female |
1.62736490949555E-12 |
| Male-vs-Female |
3.698800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.10855769008822E-12 |
| Normal-vs-Age(41-60Yrs) |
3.10862446895044E-15 |
| Normal-vs-Age(61-80Yrs) |
1.62481139653892E-12 |
| Normal-vs-Age(81-100Yrs) |
2.15039097639647E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.684600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.307200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.753800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.755000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.127600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.736400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.10729999613923E-08 |
| Normal-vs-Grade 2 |
1.65989444411707E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
6.130400E-01 |
| Grade 1-vs-Grade 3 |
1.059350E-01 |
| Grade 1-vs-Grade 4 |
2.856300E-02 |
| Grade 2-vs-Grade 3 |
2.781400E-03 |
| Grade 2-vs-Grade 4 |
5.997500E-04 |
| Grade 3-vs-Grade 4 |
2.635000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.97708516225248E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
1.374210E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.99840144432528E-15 |
| Normal-vs-N1 |
1.33759999743077E-08 |
| N0-vs-N1 |
8.188600E-01 |
|
|
